Concepedia

Kayoko Kanda

KK

6

Publications

219

Citations

6

H-Index

1992

Active since

Affiliations

Stanford University(Current)

Karolinska Institutet

VA Palo Alto Health Care System

Kayoko Kanda is an author at Stanford University specializing in gene expression, medicine, and cell biology.

Top concepts

Publications per year

1992–2007

6

Publications

6

The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.

Kayoko Kanda, Thomas Decker, Pierre Åman et al. · Molecular and Cellular Biology · 1992 · 72 citations · Full text

, , +16

NF-κB Activity Is Required for the Deregulation of c-myc Expression by the Immunoglobulin Heavy Chain Enhancer

Kayoko Kanda, Hsien‐Ming Hu, Lu Zhang et al. · Journal of Biological Chemistry · 2000 · 55 citations · Full text

The Epstein-Barr Virus Nuclear Antigen 2 (EBNA2), a Protein Required for B Lymphocyte Immortalization, Induces the Synthesis of Type I Interferon in Burkitts Lymphoma Cell Lines

Kayoko Kanda, Bettina Kempkes, Georg W. Bornkamm et al. · Biological Chemistry · 1999 · 32 citations

Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer

Hong‐Ming Hu, Kayoko Kanda, Lu Zhang et al. · Leukemia · 2007 · 27 citations

, , +6

The EBNA2-Related Resistance Towards Alpha Interferon (IFN-<i>α</i>) in Burkitt’s Lymphoma Cells Effects Induction of IFN-Induced Genes but Not the Activation of Transcription Factor ISGF-3

Kayoko Kanda, Thomas Decker, Pierre Åman et al. · Molecular and Cellular Biology · 1992 · 20 citations

, , +20

Rows per page

1–5 of 6